A twenty-four-year-old Nigerian Law School student, Mbachu Anderson Chukwudera, is seeking N40 million for a kidney transplant.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing ...

"The case highlights a critical, albeit rare, side effect of lenvatinib in the treatment of VHL syndrome, pointing to the necessity of individualized treatment strategies, vigilant monitoring, and ...